Dang Wu

3.8k total citations · 1 hit paper
56 papers, 2.5k citations indexed

About

Dang Wu is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Dang Wu has authored 56 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 22 papers in Immunology and 20 papers in Molecular Biology. Recurrent topics in Dang Wu's work include Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (11 papers) and Immune cells in cancer (7 papers). Dang Wu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (11 papers) and Immune cells in cancer (7 papers). Dang Wu collaborates with scholars based in China, United States and Taiwan. Dang Wu's co-authors include Pin Wu, Jian Huang, Ying Chai, Jun Ye, Zhigang Chen, Li‐Jun Li, Fuming Qiu, Zhigang Zhang, Chao Ni and Qichun Wei and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Dang Wu

51 papers receiving 2.5k citations

Hit Papers

Radiation-induced tumor i... 2023 2026 2024 2023 25 50 75 100

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dang Wu 1.1k 934 802 564 333 56 2.5k
Michael J. Campbell 1.0k 0.9× 939 1.0× 1.2k 1.5× 653 1.2× 243 0.7× 57 2.6k
Pedro Miguel Lacal 1.4k 1.3× 2.3k 2.5× 622 0.8× 595 1.1× 248 0.7× 101 3.8k
Yanhong Gu 1.1k 1.0× 1.5k 1.6× 910 1.1× 450 0.8× 504 1.5× 118 3.2k
An Wouters 965 0.9× 1.1k 1.2× 355 0.4× 497 0.9× 388 1.2× 73 2.2k
Sizhi Paul Gao 1.1k 1.0× 1.1k 1.2× 284 0.4× 576 1.0× 401 1.2× 32 2.3k
Manabu Emi 1.1k 1.0× 1.2k 1.3× 1.0k 1.3× 366 0.6× 685 2.1× 98 3.3k
Rachel A. O’Keefe 1.1k 1.0× 1.1k 1.2× 684 0.9× 463 0.8× 281 0.8× 12 2.4k
Michèle Sabbah 962 0.9× 1.6k 1.7× 352 0.4× 544 1.0× 214 0.6× 81 2.7k

Countries citing papers authored by Dang Wu

Since Specialization
Citations

This map shows the geographic impact of Dang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dang Wu more than expected).

Fields of papers citing papers by Dang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dang Wu. The network helps show where Dang Wu may publish in the future.

Co-authorship network of co-authors of Dang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Dang Wu. A scholar is included among the top collaborators of Dang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dang Wu. Dang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Dang, Seng‐Kee Chuah, John Y. Kao, et al.. (2025). Comparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagus. Journal of the Formosan Medical Association.
3.
Guo, Siyu, et al.. (2024). Primary Large-Cell Neuroendocrine Carcinoma of the Breast. Diagnostics. 14(21). 2347–2347.
4.
Wu, Wenxuan, et al.. (2024). JAML promotes the antitumor role of tumor-resident CD8+ T cells by facilitating their innate-like function in human lung cancer. Cancer Letters. 590. 216839–216839. 4 indexed citations
5.
Guo, Siyu, Yihan Yao, Zengfeng Xin, et al.. (2023). Radiation-induced tumor immune microenvironments and potential targets for combination therapy. Signal Transduction and Targeted Therapy. 8(1). 205–205. 109 indexed citations breakdown →
6.
7.
Chen, Xiaoke, Di Chen, Lufeng Zhao, et al.. (2022). Tissue‐resident CD69 + CXCR6 + Natural Killer cells with exhausted phenotype accumulate in human non‐small cell lung cancer. European Journal of Immunology. 52(12). 1993–2005. 11 indexed citations
8.
Wu, Pin, Lufeng Zhao, Xiaoke Chen, et al.. (2021). CD38 identifies pre-activated CD8+ T cells which can be reinvigorated by anti-PD-1 blockade in human lung cancer. Cancer Immunology Immunotherapy. 70(12). 3603–3616. 16 indexed citations
9.
Chen, Wuzhen, et al.. (2020). Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma. Aging. 12(13). 12703–12725. 14 indexed citations
10.
Liu, Zehui, Qian Hu, Wanyan Wang, et al.. (2020). Natural product piperine alleviates experimental allergic encephalomyelitis in mice by targeting dihydroorotate dehydrogenase. Biochemical Pharmacology. 177. 114000–114000. 18 indexed citations
11.
Jiang, Feng, Wei Yu, Fanrui Zeng, et al.. (2019). PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma. BMC Cancer. 19(1). 503–503. 21 indexed citations
12.
Wu, Dang, Yanhong Yang, Jin Huang, et al.. (2018). MAD2-p31comet axis deficiency reduces cell proliferation, migration and sensitivity of microtubule-interfering agents in glioma. Biochemical and Biophysical Research Communications. 498(1). 157–163. 8 indexed citations
13.
Xiao, Qiang, Xue Yao, Dang Wu, et al.. (2016). Bufexamac ameliorates LPS-induced acute lung injury in mice by targeting LTA4H. Scientific Reports. 6(1). 25298–25298. 20 indexed citations
14.
Wu, Dang, Pin Wu, Lufeng Zhao, et al.. (2015). NF-κB Expression and Outcomes in Solid Tumors. Medicine. 94(40). e1687–e1687. 81 indexed citations
15.
Wu, Dang, et al.. (2015). Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis. PLoS ONE. 10(10). e0139598–e0139598. 129 indexed citations
16.
Han, Yuehua, Jun Ye, Dang Wu, et al.. (2014). LEIGClong non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition. BMC Cancer. 14(1). 932–932. 71 indexed citations
17.
Wu, Dang, Pin Wu, Qi Huang, et al.. (2013). Interleukin-17: A Promoter in Colorectal Cancer Progression. SHILAP Revista de lepidopterología. 2013. 1–7. 98 indexed citations
18.
Chen, Zhigang, Xin He, Wenjie Xia, et al.. (2013). Prognostic Value and Clinicopathological Differences of HIFs in Colorectal Cancer: Evidence from Meta-Analysis. PLoS ONE. 8(12). e80337–e80337. 32 indexed citations
19.
Ye, Jun, Xianguo Wu, Dang Wu, et al.. (2013). miRNA-27b Targets Vascular Endothelial Growth Factor C to Inhibit Tumor Progression and Angiogenesis in Colorectal Cancer. PLoS ONE. 8(4). e60687–e60687. 142 indexed citations
20.
Zhuge, Zhengbing, Yujun Zhu, Dang Wu, et al.. (2007). Unilateral low-frequency stimulation of central piriform cortex inhibits amygdaloid-kindled seizures in Sprague–Dawley rats. Neuroscience. 146(3). 901–906. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026